Mansuo L Shannon
About Mansuo L Shannon
Mansuo L Shannon serves as the Chief Scientific Officer at Asklepios BioPharmaceutical, Inc. since 2024, bringing extensive experience in neuroscience and pharmacology from previous roles at Eli Lilly and Merck.
Work at Asklepios BioPharmaceutical
Mansuo L Shannon currently serves as the Chief Scientific Officer at Asklepios BioPharmaceutical, Inc. (AskBio), a position he has held since 2024. In this role, he is responsible for overseeing the scientific direction and research initiatives of the company. His leadership is expected to enhance AskBio's focus on developing innovative therapies, particularly in the fields of neuroscience and rare diseases.
Previous Experience at Eli Lilly and Company
Prior to joining AskBio, Mansuo L Shannon worked at Eli Lilly and Company for several years in various roles. He served as Senior Director from 2019 to 2021 in the United Kingdom, and as Senior Research Advisor from 2016 to 2018. His earlier positions included Principal Scientist from 2012 to 2015 and Research Advisor from 2015 to 2016. He also held the position of Research Fellow for a brief period in 2018-2019.
Research Background and Education
Mansuo L Shannon has a strong educational background in the life sciences. He earned a PhD in Molecular Biology from Princeton University and completed a postdoctoral fellowship in Neuroscience at the Massachusetts Institute of Technology. His academic training has provided him with a solid foundation for his extensive research and development expertise in neuroscience, rare diseases, pharmacology, and translational biomarkers.
Experience at Merck and Other Organizations
Before his tenure at Eli Lilly, Mansuo L Shannon worked at Merck, where he held multiple roles, including Research Fellow and Biology Program Team Leader. His experience at Merck spanned from 2007 to 2011. Additionally, he worked at Chugai Pharmaceutical, a Roche Group company, as a Specialist for one year in Japan. His diverse experience across these organizations has contributed to his expertise in drug development and research.
Interests and Training
Mansuo L Shannon has expressed increasing interests in artificial intelligence, particularly in its applications within the pharmaceutical and biotechnology sectors. He has also been trained under Nobel Laureate Dr. Susumu Tonegawa, which has influenced his approach to research and innovation in neuroscience.